It jarrs a little bit but on further examination it actually looks ok. I think there's a significant cohort here looking at the DR's move and his new interests with a keen eye to invest there as well.
I am at any rate. He moves from a company that he has helped fashion into potential medical powerhouse to new challenges- I wish him all the best too.